The US Hearing Aid Boom: Decoding the FDA's OTC Rule and 2025 Market Strategy

This episode explores the transformation of the U.S. hearing aid market following the FDA's landmark 2022 rule that established an over-the-counter (OTC) category. We analyze the impact on accessibility, device innovation, and affordability, while also examining the continued importance of the prescription hearing aid channel. The discussion covers early market analyses from 2024 and the outlook for 2025, highlighting the factors that make hearing aids a key medical device category. - What was the FDA's landmark hearing aid rule in 2022? - How did the creation of an OTC category change market access for consumers? - Why did so few people who needed hearing aids use them historically? - What technological innovations are emerging in OTC hearing aids? - What is the ongoing role of prescription hearing aids fitted by audiologists? - What do early 2024 and 2025 analyses reveal about the new market? - Why are hearing aids one of the most popular device categories for 2025? - How can manufacturers navigate this dual OTC and prescription market? Pure Global offers end-to-end regulatory consulting for MedTech and IVD companies, streamlining global market access with local expertise and advanced AI. We act as your local representative in over 30 markets, developing efficient regulatory strategies and using AI to compile technical dossiers. From initial market research to post-market surveillance, our integrated approach helps you expand efficiently. Whether you're a startup or a multinational enterprise, Pure Global provides the solutions to get your innovations to patients faster. To learn more, visit us at https://pureglobal.com, contact [email protected], or explore our FREE AI tools and database at https://pureglobal.ai.